Yeung et al., 2001 - Google Patents
Tissue Targeted and Regulated Gene ExpressionYeung et al., 2001
View HTML- Document ID
- 10284587672627241847
- Author
- Yeung S
- Tufaro F
- Qiang D
- Zager J
- Delman K
- Fong Y
- Horsburgh B
- Publication year
- Publication venue
- Molecular Therapy
External Links
Snippet
Methods: Twelve healthy horses were randomly assigned to six groups, two horses in each group. On Day 0, lameness and clinical measurements of the forelimb metacarpophalangial joints were obtained. Synovial fluid analysis and synovial biopsy were also performed …
- 210000001519 tissues 0 title abstract description 37
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shariat et al. | Adenovirus-mediated transfer of inducible caspases: a novel “death switch” gene therapeutic approach to prostate cancer | |
| JP6800863B2 (en) | Optimized Human Coagulation Factor VIII Gene Expression Cassette and Its Use | |
| JP7263327B2 (en) | Non-Integrating DNA Vectors for Genetic Modification of Cells | |
| AU763714B2 (en) | Gene therapy vectors and their use in antitumour therapy | |
| Biglari et al. | Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model | |
| WO2016061073A1 (en) | Composition and method for in vivo engineering of chromosomal rearrangements | |
| US7442688B2 (en) | Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation | |
| JPH11506302A (en) | Tissue-specific hypoxia-regulated therapeutic constructs | |
| KR20210133993A (en) | CRISPR/RNA-guided nuclease-related methods and compositions for treating RHO-associated autosomal-dominant retinitis pigmentosa (ADRP) | |
| JP2015506695A (en) | Adenovirus-based biological delivery and expression systems used in the treatment of osteoarthritis | |
| WO2019236081A1 (en) | Targeted gene activation using modified guide rna | |
| CN103981155B (en) | The structure method of liver cancer targeting oncolytic adenovirus and application | |
| CN116254246A (en) | Engineered CAS12B effector proteins and methods of use thereof | |
| US6867036B1 (en) | Gene expression by positive feedback activation of a cell type-specific promoter | |
| Peng et al. | Regulated expression of diphtheria toxin in prostate cancer cells | |
| WO2000024912A9 (en) | Use of a self-cleaving rna motif to modulate gene expression | |
| JP2003500422A (en) | Osteonectin-based toxic gene therapy to treat calcified tumors and tissues | |
| JP2025525583A (en) | Non-immunogenic circular non-viral DNA vectors | |
| Yeung et al. | Tissue Targeted and Regulated Gene Expression | |
| AU769773B2 (en) | Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues | |
| CN114765991A (en) | Non-pigmented ciliary epithelial cell specific promoters | |
| EP1478750A2 (en) | Gene expression by positive feedback activation of a cell type-specific promoter | |
| CN103981185A (en) | Liver cancer specific GP73 core promoter and screening building method thereof | |
| US20030213006A1 (en) | Beta-hcg promoter based tumor restrictive gene expression for cancer theraphy | |
| CA2410094A1 (en) | Compositions and methods for modulating tumor specific expression |